Britannia Life Sciences, Inc.

  • Market Cap: Micro Cap
  • Industry: Other Agricultural Products
  • ISIN: CA11042D1087
CAD
0.07
-0.01 (-6.25%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Inter-Rock Minerals, Inc.
Auxly Cannabis Group, Inc.
Britannia Life Sciences, Inc.
StateHouse Holdings, Inc.
Burcon NutraScience Corp.
Optimi Health Corp.
Mountain Valley MD Holdings, Inc.
Global Hemp Group, Inc.
Heritage Cannabis Holdings Corp.
Body & Mind, Inc.
Cansortium, Inc.

Why is Britannia Life Sciences, Inc. ?

1
The company has declared Negative results for the last 4 consecutive quarters
  • NET PROFIT(Q) At CAD -0.14 MM has Fallen at -203.69%
  • OPERATING CASH FLOW(Y) Lowest at CAD 1.11 MM
  • ROCE(HY) Lowest at -175.45%
2
Risky - Negative EBITDA
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of 60.00%, its profits have fallen by -797%
stock-recommendationReal-Time Research Report

Verdict Report

How much should you hold?

  1. Overall Portfolio exposure to Britannia Life Sciences, Inc. should be less than 10%
  2. Overall Portfolio exposure to Other Agricultural Products should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Other Agricultural Products)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Britannia Life Sciences, Inc. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Britannia Life Sciences, Inc.
15.38%
0.15
221.71%
S&P/TSX 60
29.6%
1.43
14.72%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
20.40%
EBIT Growth (5y)
12.09%
EBIT to Interest (avg)
-1.39
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
4.92
Sales to Capital Employed (avg)
0.47
Tax Ratio
3.51%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
2.09%
ROE (avg)
4.44%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
1
Industry P/E
Price to Book Value
0.80
EV to EBIT
1.63
EV to EBITDA
1.87
EV to Capital Employed
-1.33
EV to Sales
-0.79
PEG Ratio
0.01
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
61.94%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
No Trend
No Trend
OBV
Bearish
Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

1What is working for the Company
RAW MATERIAL COST(Y)

Fallen by -223.61% (YoY

0What is not working for the Company
NO KEY NEGATIVE TRIGGERS

Here's what is working for Britannia Life Sciences, Inc.

Raw Material Cost
Fallen by -223.61% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales